An open-label pilot study of fluvoxamine for mixed anxiety-depression

Psychopharmacology Bulletin

Volumn 34, Issue 2, 1998, Pages 225-227

  Houck, Carl ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antidepressants; Anxiety; Anxiolytics; Depression; Fluvoxamine

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY NEUROSIS; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; INDIGESTION; INSOMNIA; NAUSEA; PRIORITY JOURNAL; VERTIGO;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 0031842785     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
2. Boulenger, JP, and Lavallee, Y-J. Mixed anxiety and depression: Diagnostic issues. J. Clin. Psychiatry 54(Suppl.):3-8, 1993.
3. Den Boer, JA; Westenberg, HGM; and Kamerbeek, WDJ. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacol. 2:21-32, 1987.
4. Derogatis, LR. SCL-90: Administration, Scoring, and Procedures Manual for the Revised Version. Baltimore, MD: Clinical Psychometrics Research Unit, 1977.
5. Guelfi, JD, and Drefus, JF. The G.E.P.E.C.E.P. Fluvoxamine: Efficacy and tolerance of a new antidepressant in a large multicentre study. Clin. Neuropharmacol. 7(Suppl. 1):s312-s319, 1984.
6. Gulley, LR, and Nemeroff, CB. The neurobiological basis of mixed depression - Anxiety states. J. Clin. Psychiatry 54(Suppl.):16-19, 1993.
7. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-62, 1960.
8. Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:50-55, 1959.
9. Lydiard, RB. Coexisting depression and anxiety: Special diagnostic and treatment issues. J. Clin. Psychiatry 52(Suppl.):48-54, 1991.
10. National Institute of Mental Health. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol. Bull. 21(4), 1985.
11. Paul, SM. Anxiety and depression: A common neurobiological substrate? J. Clin. Psychiatry 49(Suppl.):13-16, 1988.
12. Perse, TL; Groest, JH; and Jefferson, JW. Fluvoxamine treatment of obsessive-compulsive disorder. Am. J. Psychiatry 144:1543-1548, 1987.
13. Preskorn, SH, and Fast, GA. Beyond signs and symptoms: The case against a mixed anxiety and depression category. J. Clin. Psychiatry 54(Suppl.):24-32, 1993.
14. Rickels, K, and Schweizer, E. The treatment of generalized anxiety disorder in patients with depressive symptomatology. J. Clin. Psychiatry 54(Suppl.):20-23, 1993.
15. Stahl, SM. Mixed anxiety and depression: Clinical impressions. J. Clin. Psychiatry 54(Suppl.):33-38, 1993.
16. Stein, MB; Kirk, P; Prabhu, V; Grott, M; and Terepa, M. Mixed anxiety-depression in a primary care clinic. J. Affect. Disord. 34:79-84, 1995.
17. Wittchen, HU, and Essau, CA. Comorbidity and mixed anxiety-depressive disorders: Is there epidemiologic evidence? J. Clin. Psychiatry 54(Suppl.):9-15, 1993.
18. Wright, JH, and Denber, HCB. Clinical trial of fluvoxamine: A new serotonergic antidepressant. Curr. Ther. Res. 23:83-89, 1978.
19. Zajecka, JM, and Ross, JS. Management of comorbid anxiety and depression. J. Clin. Psychiatry 56(Suppl. 2):10-13, 1995.
20. Zinbarg, RE; Barlow, DH; Liebowitz, M; Street, L; Broadhead, E; Katon, W; Roy-Byrne, P; Lepine, JP; Teherani, M; Richards, J; Brantley, PJ; and Kraemer, H. The DSM-IV Field Trial for Mixed Anxiety-Depression. Am. J. Psychiatry 151:1153-1161, 1994.